BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
17 results:

  • 1. LINC00963: A potential cancer diagnostic and therapeutic target.
    Xie Z; Zhong C; Shen J; Jia Y; Duan S
    Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett's Progression to Esophageal Adenocarcinoma.
    Ray P; Nancarrow DJ; Ferrer-Torres D; Wang Z; San Martinho M; Hinton T; Wu JH; Wu A; Turgeon DK; Hammer MA; Dame MK; Lawrence TS; O'Brien PJ; Spence JR; Beer DG; Ray D
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):129-149. PubMed ID: 34416429
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis.
    Wu T; Zhang ZT; Li L; Liu RY; Bei BT
    World J Surg Oncol; 2021 Jul; 19(1):210. PubMed ID: 34256803
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ABO Blood Groups, Rh Factor, and Thyroid cancer Risk: To 'B' or Not to 'B'.
    Tam AA; Özdemir D; Fakı S; Bilginer MC; Ersoy R; Çakır B
    Endocr Res; 2020; 45(2):137-146. PubMed ID: 31760829
    [No Abstract]    [Full Text] [Related]  

  • 5. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for head and neck cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis.
    Li H; Wang F; Fei Y; Lei Y; Lu F; Guo P; Li W; Xun X
    Oncol Rep; 2018 Aug; 40(2):647-658. PubMed ID: 29916534
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of nono induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.
    Cheng R; Zhu S; Guo S; Min L; Xing J; Guo Q; Li P; Zhang S
    Oncol Rep; 2018 Jun; 39(6):2575-2583. PubMed ID: 29620226
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Melanotic PEComa of the Sinonasal Mucosa With nono-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.
    McGregor SM; Alikhan MB; John RA; Kotler H; Bridge JA; Mujacic I; Kadri S; Segal J; Krausz T
    Am J Surg Pathol; 2017 May; 41(5):717-722. PubMed ID: 28009605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis.
    Wang W; Liu L; Wang Z; Lu X; Wei M; Lin T; Zhang Y; Jiang S; Wang Q; Cao Z; Shi M
    Cancer Causes Control; 2014 Oct; 25(10):1369-77. PubMed ID: 25064033
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Development of new methods for the diagnosis of nasopharyngeal carcinoma].
    Pi GH; Cheng DS; Zhou Y; Zhang WL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):65-7. PubMed ID: 20848856
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
    Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
    Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
    Wan Z; Pi G; Sun N
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.
    Dardari R; Hinderer W; Lang D; Benider A; El Gueddari B; Joab I; Benslimane A; Khyatti M
    J Clin Microbiol; 2001 Sep; 39(9):3164-70. PubMed ID: 11526145
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization.
    Lo AK; Liu Y; Wang X; Wong YC; Kai Fai Lee C; Huang DP; Tsao SW
    Biochim Biophys Acta; 2001 Aug; 1520(2):131-40. PubMed ID: 11513954
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.